BiomX Inc. (PHGE)
NYSEAMERICAN: PHGE · Real-Time Price · USD
0.4963
-0.0657 (-11.69%)
At close: Aug 13, 2025, 4:00 PM
0.4918
-0.0045 (-0.91%)
Pre-market: Aug 14, 2025, 9:18 AM EDT
BiomX Employees
As of December 31, 2024, BiomX had 57 total employees, including 52 full-time and 5 part-time employees. The number of employees decreased by 14 or -19.72% compared to the previous year.
Employees
57
Change (1Y)
-14
Growth (1Y)
-19.72%
Revenue / Employee
n/a
Profits / Employee
-$325,737
Market Cap
12.99M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PHGE News
- 21 hours ago - BiomX Inc. (PHGE) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - BiomX Reports Second Quarter 2025 Financial Results and Provides Program Updates - GlobeNewsWire
- 8 days ago - BiomX to Report Second Quarter 2025 Financial Results and Program Updates on August 13, 2025 - GlobeNewsWire
- 4 weeks ago - BiomX Announces Successful Initiation of Phase 2b Trial with First Patient Dosed in BX004 Program in Patients with Cystic Fibrosis - GlobeNewsWire
- 5 weeks ago - BiomX Announces Publication in Nature Communications of Phage Cocktail BX004 Phase 1b/2a Part 1 Data Demonstrating Strong Activity in Cystic Fibrosis - GlobeNewsWire
- 3 months ago - BiomX CEO Jonathan Solomon to Present at Biomed Israel 2025 Conference - GlobeNewsWire
- 3 months ago - BiomX Inc. (PHGE) Q1 2025 Earnings Conference Call Transcript - Seeking Alpha
- 3 months ago - BiomX Reports First Quarter 2025 Financial Results and Provides Business and Program Updates - GlobeNewsWire